ABATE KRISTIN (Chief Accounting Officer) sold 0.2% of their position (50.00 shares) of KARYOPHARM THERAPEUTICS INC. on the open market
Open‑market sale worth $351.50 — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/29/2026ACC: 0001193125-26-029599
Officer· Chief Accounting Officer
Since Mar 2026
+42.00
Net shares
Net buyer
$351.50
Total sold
1
Open market trades
0B · 1S
2
Total transactions
92.00 acquired · 50.00 disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+92.00
Price / share
—
Trade value
—
% of position
0.4%
1/27/2026
22.58K→22.67K
Common Stock
Direct
Shares
−50.00
Price / share
$7.03
Trade value
$351.50
% of position
0.2%
1/28/2026
22.67K→22.62K
Total
Net shares
+42.00
Net value
-$351.50
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/27/2026 | A · Award | +92.00 | — | — | 0.4% | 22.58K | 22.67K |
| Common Stock Direct | 1/28/2026 | S · Sale | −50.00 | $7.03 | $351.50 | 0.2% | 22.67K | 22.62K |
| Total | +42.00 | -$351.50 | ||||||
Derivative Transactions0
No derivative transactions reported